Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
Kadriu B, Yuan S, Farmer C, Nugent AC, Lener MS, Niciu MJ, Park M, Yazdian A, Ballard ED, Henn FA, Henter ID, Park LT, Zarate CA Jr.
Kadriu B, et al. Among authors: park lt, park m.
J Clin Psychopharmacol. 2018 Jun;38(3):243-246. doi: 10.1097/JCP.0000000000000866.
J Clin Psychopharmacol. 2018.
PMID: 29601316
Free PMC article.
Clinical Trial.